Clinical Trial Update: Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies [Phase 1]

View source ↗

Summary

A phase 1 trial from St. Jude Children’s Research Hospital evaluates irinotecan with vincristine and dexamethasone in children with relapsed or refractory hemat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Irinotecan (Irinotecan)
• Vincristine (vincristine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Non-Hodgkins Lymphoma, Hodgkin's Disease | Phase 1 | Status: COMPLETED